Original articleClinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease*
References (10)
- et al.
Hydrops of the gallbladder associated with Kawasaki syndrome
J Pediatr Surg
(1987) - et al.
Kawasaki syndrome: association with the application of rug shampoo
Lancet
(1982) - et al.
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan
Pediatrics
(1974) - et al.
Treatment of Kawasaki syndrome with intravenous gamma globulin
N Engl J Med
(1986)
Cited by (176)
Fever and Rash
2024, Emergency Medicine Clinics of North AmericaFrench national diagnostic and care protocol for Kawasaki disease
2023, Revue de Medecine InterneOtorhinolaryngological manifestations and delayed diagnosis in Kawasaki disease
2019, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :This is also comparable to what was found in our study (41.5%). Among the oropharyngeal attacks, cheilitis is the most frequent symptom in series (respectively 94%, 74% and 63% for series of Burns et al. [10], Kryzer and Derkay [11], Sung and Al [13]) as well as in our study (83%). This symptom should attract the attention of the clinician since it is not classical during ordinary ENT infections.
Kawasaki Disease Substantially Impacts Health-Related Quality of Life
2018, Journal of PediatricsCitation Excerpt :Similar comparisons between KD and acute, noncomplex pneumonia subjects, revealed a substantial deterioration for the former group. KD shares common lymphomucocutaneous features with infectious processes.32 However, extreme irritability is a hallmark KD symptom,33 which leads to a pronounced degree of behavioral dysfunction and potentially explains the profound HRQoL decline with illness onset.
Laboratory Manifestations of Infectious Diseases
2018, Principles and Practice of Pediatric Infectious Diseases
- *
Presented in part at the 30th Interscience Congress of Antimicrobial Agents and Chemotherapy, Atlanta, Ga., October 1990.
Supported in part by U.S. Public Health Service grants HL-01855 and HL-34545, and by CRC grant RR69, General Clinical Research Centers, Program of the Division of Resources, National Institutes of Health.